ABSITE Questions With Complete Solutions
(Guaranteed Pass)
hypodense, low-attenuation lesion with mild enhancement on arterial-phase
computed tomography Right Ans - metastasis to liver (imaging)
peripheral-to-central enhancement on delayed-phase computed tomography
Right Ans - hepatic hemangioma
enhancement of a central scar on delayed-phase computed tomography
Right Ans - focal nodular hyperplasia
well-circumscribed mass with bright enhancement on arterial-phase
computed tomography Right Ans - hepatic adenoma
heterogeneous, poorly circumscribed mass with bright arterial enhancement
and quick washout. Right Ans - hepatocellular carcinoma
Muir-Torre syndrome Right Ans - ∆ MLH1/MSH2 - Lynch syndrome +
sebaceous tumors and cutaneous keratoacanthomas
MELD Right Ans - creatinine, bilirubin, INR, Na
pembrolizumab Right Ans - IL-2/tumor vaccine treatment for metastatic
melanoma
R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)
Right Ans - treatment for diffuse large b-cell lymphoma
FOLFIRINOX
(folinic acid, fluorouracil, irinotecan, and oxaliplatin) Right Ans - treatment
for pancreatic adenocarcinoma
Poland Syndrome Right Ans - congenital absence of pectoralis major +/-
pectoralis minor, chest wall, ribs, breast
∆ CTNNB1 (beta-catenin) Right Ans - sporadic desmoid tumor
,Nigro regimen (5-fluorouracil + mitomycin C + 50 Gy to primary carcinoma +
35-45 Gy to inguinal lymph nodes) Right Ans - treatment of anal cancer
Frey procedure Right Ans - partial pancreatic head resection + lateral
pancreaticojejunostomic anastomosis
indication for Frey procedure Right Ans - pancreatic duct obstruction with
pancreatic head inflammation
indication for total pancreatectomy with islet cell autotransplantation
Right Ans - small pancreatic duct, minimal change pancreatitis, and hereditary
pancreatitis (best procedure)
indication for Whipple Right Ans - pancreatic duct obstruction, bile duct
obstruction, inflammatory pancreatic head mass and any suspicion of cancer.
indication for modified Puestow Right Ans - dilated pancreatic duct (> 6
mm) without inflammatory changes in the pancreatic head.
modified Puestow procedure Right Ans - longitudinal/lateral
pancreaticojejunostomy
dacarbazine Right Ans - chemotherapy treatment for metastatic melanoma
basal cell carcinoma pathology Right Ans - peripheral palisading of nuclei
and stromal retraction
basal cell carcinoma appearance Right Ans - pearly, pink lesion, skin thin
enough to see blood vessels, rolled borders
nodular melanoma appearance Right Ans - blu-ish black with smooth
borders
squamous cell carcinoma appearance Right Ans - overlying erythema,
papulonodular with crust and ulceration, red-brown
basal cell carcinoma margins Right Ans - 0.3-0.5 cm margins (skin cancer)
, squamous cell carcinoma margins Right Ans - 0.5-1 cm margins (skin
cancer)
melanoma in-situ margins Right Ans - 0.5 cm margins (skin cancer)
<1.0 mm melanoma margins Right Ans - 1.0 cm margins (skin cancer)
1.1-2.0 mm melanoma margins Right Ans - 1.0-2.0 cm margins (skin
cancer)
>2.0 mm melanoma margins Right Ans - 2.0 cm margins (skin cancer)
doxorubicin Right Ans - treatment for soft tissue sarcoma (including
rhabdomyosarcoma/Botryoides tumor)
tuberous sclerosis Right Ans - angiomyolipoma, ash leaf spots
neurofibromatosis Right Ans - neuromas, café-au-lait spots,
pheochromocytomas
Merkle cell carcinoma Right Ans - aggressive, malignant neuroendocrine
tumor, red/purple papulonodule or indurated plaque
Merkle cell carcinoma proteins Right Ans - NSE (neuron-specific enolase),
cytokeratin, neurofilament protein
Merkel cell carcinoma margins Right Ans - 2-3 cm margins (skin cancer)
suldinac + tamoxifen Right Ans - treatment for desmoid tumor
imiquimod Right Ans - treatment for Bowen's disease
Bowen's disease margins Right Ans - avoid wide local excision (skin
cancer)
keratoacanthoma Right Ans - rapid growth, rolled edges, crater filled with
keratin
norepinephrine Right Ans - first-line vasopressor used in septic shock
(Guaranteed Pass)
hypodense, low-attenuation lesion with mild enhancement on arterial-phase
computed tomography Right Ans - metastasis to liver (imaging)
peripheral-to-central enhancement on delayed-phase computed tomography
Right Ans - hepatic hemangioma
enhancement of a central scar on delayed-phase computed tomography
Right Ans - focal nodular hyperplasia
well-circumscribed mass with bright enhancement on arterial-phase
computed tomography Right Ans - hepatic adenoma
heterogeneous, poorly circumscribed mass with bright arterial enhancement
and quick washout. Right Ans - hepatocellular carcinoma
Muir-Torre syndrome Right Ans - ∆ MLH1/MSH2 - Lynch syndrome +
sebaceous tumors and cutaneous keratoacanthomas
MELD Right Ans - creatinine, bilirubin, INR, Na
pembrolizumab Right Ans - IL-2/tumor vaccine treatment for metastatic
melanoma
R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone)
Right Ans - treatment for diffuse large b-cell lymphoma
FOLFIRINOX
(folinic acid, fluorouracil, irinotecan, and oxaliplatin) Right Ans - treatment
for pancreatic adenocarcinoma
Poland Syndrome Right Ans - congenital absence of pectoralis major +/-
pectoralis minor, chest wall, ribs, breast
∆ CTNNB1 (beta-catenin) Right Ans - sporadic desmoid tumor
,Nigro regimen (5-fluorouracil + mitomycin C + 50 Gy to primary carcinoma +
35-45 Gy to inguinal lymph nodes) Right Ans - treatment of anal cancer
Frey procedure Right Ans - partial pancreatic head resection + lateral
pancreaticojejunostomic anastomosis
indication for Frey procedure Right Ans - pancreatic duct obstruction with
pancreatic head inflammation
indication for total pancreatectomy with islet cell autotransplantation
Right Ans - small pancreatic duct, minimal change pancreatitis, and hereditary
pancreatitis (best procedure)
indication for Whipple Right Ans - pancreatic duct obstruction, bile duct
obstruction, inflammatory pancreatic head mass and any suspicion of cancer.
indication for modified Puestow Right Ans - dilated pancreatic duct (> 6
mm) without inflammatory changes in the pancreatic head.
modified Puestow procedure Right Ans - longitudinal/lateral
pancreaticojejunostomy
dacarbazine Right Ans - chemotherapy treatment for metastatic melanoma
basal cell carcinoma pathology Right Ans - peripheral palisading of nuclei
and stromal retraction
basal cell carcinoma appearance Right Ans - pearly, pink lesion, skin thin
enough to see blood vessels, rolled borders
nodular melanoma appearance Right Ans - blu-ish black with smooth
borders
squamous cell carcinoma appearance Right Ans - overlying erythema,
papulonodular with crust and ulceration, red-brown
basal cell carcinoma margins Right Ans - 0.3-0.5 cm margins (skin cancer)
, squamous cell carcinoma margins Right Ans - 0.5-1 cm margins (skin
cancer)
melanoma in-situ margins Right Ans - 0.5 cm margins (skin cancer)
<1.0 mm melanoma margins Right Ans - 1.0 cm margins (skin cancer)
1.1-2.0 mm melanoma margins Right Ans - 1.0-2.0 cm margins (skin
cancer)
>2.0 mm melanoma margins Right Ans - 2.0 cm margins (skin cancer)
doxorubicin Right Ans - treatment for soft tissue sarcoma (including
rhabdomyosarcoma/Botryoides tumor)
tuberous sclerosis Right Ans - angiomyolipoma, ash leaf spots
neurofibromatosis Right Ans - neuromas, café-au-lait spots,
pheochromocytomas
Merkle cell carcinoma Right Ans - aggressive, malignant neuroendocrine
tumor, red/purple papulonodule or indurated plaque
Merkle cell carcinoma proteins Right Ans - NSE (neuron-specific enolase),
cytokeratin, neurofilament protein
Merkel cell carcinoma margins Right Ans - 2-3 cm margins (skin cancer)
suldinac + tamoxifen Right Ans - treatment for desmoid tumor
imiquimod Right Ans - treatment for Bowen's disease
Bowen's disease margins Right Ans - avoid wide local excision (skin
cancer)
keratoacanthoma Right Ans - rapid growth, rolled edges, crater filled with
keratin
norepinephrine Right Ans - first-line vasopressor used in septic shock
